{"id":"W2911723829","doi":"10.1007/s40264-019-00797-3","title":"Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn’s Disease: An Integrated Analysis of Phase II/III Clinical Development Programs","year":2019,"lang":"en","type":"article","venue":"Drug Safety","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"Janssen Research and Development","keywords":"Medicine; Ustekinumab; Psoriatic arthritis; Psoriasis; Placebo; Internal medicine; Psoriasis Area and Severity Index; Methotrexate; Dermatology; Dosing; Gastroenterology; Adalimumab; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007245278,0.0003137037,0.001325809,0.0003095152,0.0001399114,0.00001747248,0.0001037483,0.0001092094,0.0003445001],"category_scores_gemma":[0.00009870313,0.0002628249,0.0002434221,0.0009919815,0.0001428643,0.00012787,0.0001226481,0.0002368747,0.00001169892],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001768481,"about_ca_system_score_gemma":0.000272435,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003461007,"about_ca_topic_score_gemma":0.002264197,"domain_scores_codex":[0.9970649,0.0001635457,0.001314233,0.000656785,0.0003939838,0.0004065034],"domain_scores_gemma":[0.9985942,0.0001179134,0.000250501,0.000516229,0.0001598939,0.0003612263],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.00477311,0.004032521,0.2968846,0.00005417866,0.001859392,0.0001883415,0.001580877,0.00001081092,0.000003841156,0.0001186912,0.00003669775,0.6904569],"study_design_scores_gemma":[0.03355073,0.0008574073,0.9441752,0.0006262354,0.00134216,0.000006874777,0.001439664,0.0009712902,0.00001733784,0.00001765727,0.0166912,0.0003041869],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939295,0.003836179,0.00005047932,0.0002005662,0.0002770503,0.001232047,0.0001205239,0.00005256314,0.0003010584],"genre_scores_gemma":[0.9928341,0.003733836,0.001451031,0.00009140738,0.00005083669,0.00006454479,0.001314337,0.00002610658,0.0004337945],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6901528,"threshold_uncertainty_score":0.9999824,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01842427804209179,"score_gpt":0.3197942799163208,"score_spread":0.301370001874229,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}